B. Metzler seel. Sohn & Co. Holding AG Acquires Shares of 32,947 Innospec Inc. (NASDAQ:IOSP)

B. Metzler seel. Sohn & Co. Holding AG bought a new position in shares of Innospec Inc. (NASDAQ:IOSPFree Report) during the 3rd quarter, according to the company in its most recent 13F filing with the Securities & Exchange Commission. The institutional investor bought 32,947 shares of the specialty chemicals company’s stock, valued at approximately $3,726,000. B. Metzler seel. Sohn & Co. Holding AG owned about 0.13% of Innospec as of its most recent filing with the Securities & Exchange Commission.

A number of other hedge funds and other institutional investors also recently made changes to their positions in the business. DekaBank Deutsche Girozentrale bought a new stake in Innospec during the 1st quarter worth about $66,000. CWM LLC grew its stake in shares of Innospec by 239.6% during the second quarter. CWM LLC now owns 635 shares of the specialty chemicals company’s stock valued at $78,000 after purchasing an additional 448 shares during the last quarter. Blue Trust Inc. grew its stake in shares of Innospec by 503.9% during the third quarter. Blue Trust Inc. now owns 779 shares of the specialty chemicals company’s stock valued at $96,000 after purchasing an additional 650 shares during the last quarter. nVerses Capital LLC increased its holdings in shares of Innospec by 200.0% in the third quarter. nVerses Capital LLC now owns 900 shares of the specialty chemicals company’s stock valued at $102,000 after purchasing an additional 600 shares in the last quarter. Finally, EntryPoint Capital LLC bought a new position in Innospec in the 1st quarter worth approximately $147,000. 96.64% of the stock is currently owned by institutional investors and hedge funds.

Wall Street Analyst Weigh In

Separately, StockNews.com downgraded Innospec from a “strong-buy” rating to a “buy” rating in a research report on Thursday, August 8th.

Get Our Latest Analysis on Innospec

Insider Activity at Innospec

In other Innospec news, Director Milton C. Blackmore sold 1,035 shares of the firm’s stock in a transaction that occurred on Wednesday, November 13th. The stock was sold at an average price of $122.92, for a total value of $127,222.20. Following the completion of the transaction, the director now directly owns 9,028 shares in the company, valued at $1,109,721.76. This trade represents a 10.29 % decrease in their ownership of the stock. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available through this link. Also, CFO Ian Cleminson sold 6,602 shares of the company’s stock in a transaction that occurred on Friday, August 23rd. The stock was sold at an average price of $113.60, for a total value of $749,987.20. Following the sale, the chief financial officer now owns 16,394 shares in the company, valued at approximately $1,862,358.40. This represents a 28.71 % decrease in their position. The disclosure for this sale can be found here. In the last ninety days, insiders have sold 11,035 shares of company stock valued at $1,267,096. 1.35% of the stock is owned by corporate insiders.

Innospec Trading Up 1.3 %

Innospec stock opened at $118.25 on Thursday. The company has a market cap of $2.95 billion, a PE ratio of 20.64 and a beta of 1.08. The company’s 50-day moving average is $113.41 and its two-hundred day moving average is $118.75. Innospec Inc. has a 1 year low of $103.97 and a 1 year high of $133.71.

Innospec (NASDAQ:IOSPGet Free Report) last posted its earnings results on Tuesday, November 5th. The specialty chemicals company reported $1.35 earnings per share (EPS) for the quarter, hitting the consensus estimate of $1.35. Innospec had a return on equity of 13.33% and a net margin of 7.68%. The company had revenue of $443.40 million during the quarter, compared to analyst estimates of $442.13 million. During the same period in the previous year, the company earned $1.59 EPS. The company’s revenue for the quarter was down 4.5% compared to the same quarter last year. Research analysts forecast that Innospec Inc. will post 5.88 EPS for the current year.

Innospec Increases Dividend

The business also recently disclosed a Semi-Annual dividend, which will be paid on Tuesday, November 26th. Investors of record on Monday, November 18th will be issued a dividend of $0.79 per share. This represents a dividend yield of 1.3%. This is a positive change from Innospec’s previous Semi-Annual dividend of $0.72. The ex-dividend date is Monday, November 18th. Innospec’s dividend payout ratio (DPR) is presently 26.53%.

Innospec Profile

(Free Report)

Innospec Inc develops, manufactures, blends, markets, and supplies specialty chemicals in the United States, rest of North America, the United Kingdom, rest of Europe, and internationally. The company's Fuel Specialties segment offers a range of specialty chemical products that are used as additives in additives in diesel, jet, marine, fuel oil and other fuels.

Further Reading

Want to see what other hedge funds are holding IOSP? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Innospec Inc. (NASDAQ:IOSPFree Report).

Institutional Ownership by Quarter for Innospec (NASDAQ:IOSP)

Receive News & Ratings for Innospec Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Innospec and related companies with MarketBeat.com's FREE daily email newsletter.